IMV’s DPX Delivery Technology to be Featured in Two Electronic Posters at AACR-NCI-EORTC…
Content of the article DARTMOUTH, Nova Scotia and CAMBRIDGE, Mass. - IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage biopharmaceutical company pioneering a new class of immunotherapies for difficult-to-treat cancers, today announced…